Latest Corporate Expansion Resources

A user-friendly resource for researchers, advocates, and civil society ACB is proud to release a collation of the past two decades of research done on pesticide use in South Africa, in the form of a searchable (and downloadable) database, below. For the first time, this extensive body of scientific evidence of the harm caused by […]

The endless extensions to the State of Disaster, initially declared two years ago, has provoked criticism from medical experts and calls for its end from public-interest groups and an increasingly fed-up citizenry. Recently, the government announced that the restrictions were finally to be lifted.  However, during this time, a draft amendment to the National Health […]

(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]

This submission is made by the ABC because of serious public interest concerns about the proposed merger between Bayer and Monsanto. This merger is occurring in the context of other related mergers in agricultural input supply, between ChemChina-Syngenta and Dow-Du Pont. We urge the Commission to consider the wider implications of these mergers beyond a […]

As a stakeholder, the ACB was requested by the Competition Commission to make written comments on the proposed merger between Pioneer Hi Bred and Pannar, which we submitted to the Commission on the 21st of October, 2010. In this submission, we raise the following further pertinent issues: We provide in several annexes, the seeds under […]

The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]